Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RDHL will decline by -12.91% over the next 2 Weeks and hit $0.78 by Monday, September 14, 2026. In that time frame, RDHL's share price is expected to range between $0.74 and $0.83.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 14, 2026 | 0.74 | 0.78 | 0.83 |
| Sep 11, 2026 | 0.70 | 0.75 | 0.79 |
| Sep 10, 2026 | 0.73 | 0.77 | 0.81 |
| Sep 9, 2026 | 0.74 | 0.79 | 0.83 |
| Sep 8, 2026 | 0.74 | 0.79 | 0.83 |
| Sep 7, 2026 | 0.75 | 0.79 | 0.83 |
| Sep 4, 2026 | 0.71 | 0.75 | 0.80 |
| Sep 3, 2026 | 0.73 | 0.78 | 0.82 |
| Sep 2, 2026 | 0.75 | 0.80 | 0.84 |
| Sep 1, 2026 | 0.75 | 0.79 | 0.84 |
RDHL shares rose +36.16% in Monday, August 31, 2026's trading session, rising from a previous close of $0.66 to move at $0.90. The stock demonstrated notable intraday movement (see RDHL's key stats for a full breakdown), fluctuating between $0.90 and $1.60, a +77.78% trading range. While recent weeks have seen some volatility, RDHL has managed to secure a +51.80% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 103.3M shares changing hands, 103.26M more than the previous session. This amounted to $92.97M in total market activity.
Will RDHL Continue Its Downward Trend?
According to analyst ratings and projections for RDHL, RedHill Biopharma Ltd. shares are anticipated to decrease by -8.63%, potentially reaching $0.83 per share by September 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for RDHL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the RDHL stock forecast, now is not the best time to buy RDHL stock because its current trading price is +14.83% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on RDHL covering social and institutional perspectives.
RDHL Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RDHL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 68.11% to 86.26%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 53.52%, suggests a neutral medium-term outlook. However, the 100-day RSI, at 46.41%, maintains a neutral outlook for the long term. Insights into RDHL's shareholder base show how institutional investors are positioning themselves during these momentum shifts
RedHill Biopharma Short-Term Forecasts
RDHL Forecast For Next 5 Days
Our algorithm anticipates RedHill Biopharma (RDHL) stock could hit $0.55 by Sep 07, 2026. This represents a -38.59% rise from today's price, following a +3.15% change over the past five days.
RDHL Forecast For Next 30 Days
Based on analysis of market trends, the outlook for RedHill Biopharma Ltd. (RDHL) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.57, which would mean a -36.67% decrease from the current price of $0.90. Projections for this period range from a high of $0.71 to a low of $0.49.
RDHL Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for RedHill Biopharma's price over the next three months point to a drop. RDHL stock is expected to peak at $1.37 on Oct 26, 2026 before potentially dipping to $0.00 on Dec 01, 2026. On average, RDHL is likely to trade around $0.14 in the coming 90 days.
RedHill Biopharma Stock Forecast 2025
Based on our predictive models, RedHill Biopharma (RDHL) is expected to trade between $0.00 and $1.37 throughout 2026. This would result in an average price of $0.15, potentially offering investors a -83.33% return from current levels.
RedHill Biopharma Ltd. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, RedHill Biopharma Ltd. (RDHL) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $1.37, settling at an average of $0.17. This could translate to a -81.11% loss.
October 2026
Based on current market signals, RedHill Biopharma Ltd. is projected to trend october 2026. We forecast a trading range from $0.00 to $1.37, with a likely average price of $0.15. Investors could expect a potential return of -83.33%.
November 2026
Our predictive algorithms indicate RedHill Biopharma Ltd. stock may see a shift in November 2026. The expected range spans $0.00–$1.31, with an average target of $0.11. This represents a cautious outlook and a possible loss of -87.78%.
December 2026
Analyzing established trends, RedHill Biopharma Ltd. looks set to move in December 2026. Projections place the stock between $0.00 and $1.36, averaging around $0.16. This suggests a -82.22% loss from current levels.
January 2027
Market indicators suggest RedHill Biopharma Ltd. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $1.46, with a midpoint forecast of $0.15. The stock might deliver a -83.33% loss.
February 2027
Forecasting for February 2027, models estimate that RedHill Biopharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.28, averaging $0.08. This signals a cautious trajectory with potential returns around -91.11%.
March 2027
According to our latest forecast models, RedHill Biopharma Ltd. (RDHL) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $1.22, settling at an average of $0.08. This could translate to a -91.11% loss.
April 2027
Based on current market signals, RedHill Biopharma Ltd. is projected to trend april 2027. We forecast a trading range from $0.00 to $1.31, with a likely average price of $0.05. Investors could expect a potential return of -94.44%.
May 2027
Our predictive algorithms indicate RedHill Biopharma Ltd. stock may see a shift in May 2027. The expected range spans $0.00–$1.28, with an average target of $0.03. This represents a cautious outlook and a possible loss of -96.67%.
June 2027
Analyzing established trends, RedHill Biopharma Ltd. looks set to move in June 2027. Projections place the stock between $0.00 and $1.16, averaging around $0.05. This suggests a -94.44% loss from current levels.
July 2027
Market indicators suggest RedHill Biopharma Ltd. could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $1.26, with a midpoint forecast of $0.03. The stock might deliver a -96.67% loss.
August 2027
Forecasting for August 2027, models estimate that RedHill Biopharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.24, averaging $0.04. This signals a cautious trajectory with potential returns around -95.56%.
RDHL's history of dividends and stock splits also plays a role in long-term investor confidence.

